Pins MR - Search Results

1

Clusterin as a possible predictor for biochemical recurrence of prostate cancer following radical prostatectomy with intermediate Gleason scores: a preliminary report.

Pins MR, Fiadjoe JE, Korley F, Wong M, Rademaker AW, Jovanovic B, Yoo TK, Kozlowski JM, Raji A, Yang XJ, Lee C. Pins MR, et al. Prostate Cancer Prostatic Dis. 2004;7(3):243-8. doi: 10.1038/sj.pcan.4500722. Prostate Cancer Prostatic Dis. 2004. PMID: 15343364 Free PMC article.

2

In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator.

Lee C, Janulis L, Ilio K, Shah A, Park I, Kim S, Cryns V, Pins M, Bergan R. Lee C, et al. Prostate Suppl. 2000;9:21-4. Prostate Suppl. 2000. PMID: 11056498 Review. No abstract available.

3

Apoptotic activity of doxazosin on prostate stroma in vitro is mediated through an autocrine expression of TGF-beta1.

Ilio KY, Park II, Pins MR, Kozlowski JM, Lee C. Ilio KY, et al. Among authors: pins mr. Prostate. 2001 Aug 1;48(3):131-5. doi: 10.1002/pros.1091. Prostate. 2001. PMID: 11494328

4

Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate.

Doll JA, Reiher FK, Crawford SE, Pins MR, Campbell SC, Bouck NP. Doll JA, et al. Among authors: pins mr. Prostate. 2001 Dec 1;49(4):293-305. doi: 10.1002/pros.10025. Prostate. 2001. PMID: 11746276

5

p53 and microvessel density in primary resection specimens of superficial bladder cancer.

Reiher F, Ozer O, Pins M, Jovanovic BD, Eggener S, Campbell SC. Reiher F, et al. J Urol. 2002 Mar;167(3):1469-74. J Urol. 2002. PMID: 11832772

6

Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomy.

Kalapurakal JA, Huang CF, Neriamparampil MM, Small WJ Jr, Pins MR, Mittal BB, Campbell SC, Grayhack JT, Shetty RM. Kalapurakal JA, et al. Among authors: pins mr. Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1047-54. doi: 10.1016/s0360-3016(02)03034-1. Int J Radiat Oncol Biol Phys. 2002. PMID: 12419430

7

Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion.

Liu Y, Jovanovic B, Pins M, Lee C, Bergan RC. Liu Y, et al. Oncogene. 2002 Nov 28;21(54):8272-81. doi: 10.1038/sj.onc.1206117. Oncogene. 2002. PMID: 12447690

8

Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells.

Liu YQ, Kyle E, Patel S, Housseau F, Hakim F, Lieberman R, Pins M, Blagosklonny MV, Bergan RC. Liu YQ, et al. Prostate Cancer Prostatic Dis. 2001;4(2):81-91. doi: 10.1038/sj.pcan.4500506. Prostate Cancer Prostatic Dis. 2001. PMID: 12497043

9

Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas.

Doll JA, Stellmach VM, Bouck NP, Bergh AR, Lee C, Abramson LP, Cornwell ML, Pins MR, Borensztajn J, Crawford SE. Doll JA, et al. Among authors: pins mr. Nat Med. 2003 Jun;9(6):774-80. doi: 10.1038/nm870. Epub 2003 May 12. Nat Med. 2003. PMID: 12740569

10

Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer.

Xiao W, Zhang Q, Jiang F, Pins M, Kozlowski JM, Wang Z. Xiao W, et al. Cancer Res. 2003 Aug 1;63(15):4698-704. Cancer Res. 2003. PMID: 12907652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters